Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.

AstraZeneca Reshuffles Management Team

AstraZeneca (NYSE: AZN  ) announced changes in its top management team in an official statement released today.The crucial post of president of research and development, currently held by the departing Martin Mackay, is to be eliminated and replaced by three individuals responsible for different pharmaceutical segments.

In addition, the company's top sales executive, Executive Vice President of Global Commercial Tony Zook, is to leave the company. His position will also be eliminated and carried out by three managers, each responsible for a different commercial region -- North America, Europe, and international.

The shakeup comes several months after the appointment of current CEO Pascal Soriot, who took his position last summer following the sudden retirement of his predecessor, David Brennan.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2197998, ~/Articles/ArticleHandler.aspx, 3/30/2015 2:10:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...